Direct-to-consumer (DTC) platforms, such as LillyDirect or NovoCare, make FDA-approved GLP-1s accessible and more affordable
The emergence of GLP-1 receptor agonistsmedications like Ozempic, Wegovy, and Mounjarohas sparked a wave of conversations about their potential to transform health outcomes, particularly in managing diabetes and supporting weight loss
The study also demonstrated the protective effect of exenatide on islet-cell function during GCs therapy, providing early evidence for using GLP-1 RAs to counteract the diabetogenic effects of GCs (34)
Low Blood Sugar While Ozempic probably does not itself cause low blood sugar (hypoglycemia), its glucose-lowering effect can sharply increase the odds that other drugs, principally insulin or sulfonylureas, cause hypoglycemia
108,109 Wu et al
For the full side effect profile, see our GLP-1 side effects guide